This is published at the 2019 National Organization of Rare Disorders (NORD) Breakthrough Summit and was the first of several NHS posters and papers at medical conferences.
by
Join us in Philadelphia this September for the DTRF "Together We Will" Weekend: - Register today!
by
This is published at the 2019 National Organization of Rare Disorders (NORD) Breakthrough Summit and was the first of several NHS posters and papers at medical conferences.
by
Building on a patient-driven campaign, the DTRF claims the month of September on behalf of the international patient community to promote awareness for desmoid tumors.
by
Per study PI, Dr. Mrinal Gounder, the DTRF provides “record-breaking” accrual during recruitment phase. Study is named by ASCO as an “Advance of the Year” and one of the top breakthroughs in Oncology in 2018.
by
This scientific paper, and the patient-friendly version, become an invaluable resource to doctors and patients worldwide.
by
~50 people attend the meeting where doctors from major nearby institutions present.
by
The Board allows doctors to present a patient’s case from anywhere in the world for input from desmoid tumor experts.
Every donation, no matter the size, helps us continue our mission.
© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677
Registered 501(c)(3). EIN: 61-1493017